As previous study, Mcl1 contributes to tumorigenesis, particularly in solid cancers [20], and second generation Mcl1 antagonists are actively being sought [10, 21], distinguishing it as a potentially important molecular marker of tumor progress. The gene discussed is MCL1; the disease is neoplasm.